TNET · Trinet Group, Inc.

The thesis

TriNet Group's case rests on whether its insurance costs stay low without July's one-time benefit, and the third-quarter report on 29 October 2026 settles it. A quarterly insurance cost ratio below the 89.5% top of full-year guidance, with revenue guidance of at least $4.75 billion intact, would support the margin recovery. A ratio at or above 89.5% would break it.

The shares closed at $71.03 on 21 October 2026, 0.4% below the 52-week high of $71.34 and 9.3% above the $65 level that ends the price case. They have risen 15.6% over three months. The narrative is maturing: the July guidance increase remains the main evidence, and TriNet has published no results since 30 July 2026. The consensus target of $56.80 sits below the share price.

Bullish and bearish views on Trinet Group, Inc.

The bull case on Trinet Group, Inc. (TNET), in brief: Insurance costs fell sharply. The bear case: The Q2 benefit was one-time.

Bull case

• Insurance costs fell sharply. TriNet's 30 July 2026 release reported a second-quarter insurance cost ratio of 86%, against 90% a year earlier. Full-year ratio guidance is 88.5–89.5%.
• Earnings guidance was raised. On 30 July 2026 the company lifted 2026 adjusted diluted earnings per share guidance to $4.50–$5.10. It held revenue guidance at $4.75–$4.90 billion.
• Some analysts see upside. Stifel rated the shares Buy with an $82 target on 30 July 2026, per Investing.com. TD Cowen rated them Hold with a $68 target, per MarketBeat.

Bear case

• The Q2 benefit was one-time. Management said on the 30 July 2026 earnings call that a $21 million recovery of prior-year health care costs, included in the 86% ratio, is not expected to recur. The guided full-year range of 88.5–89.5% implies costs rise from the second-quarter level.
• The business is shrinking. Second-quarter revenue was $1.178 billion, down 5% year over year. Worksite employees (the staff TriNet handles for its small-business clients) were 299,655, down 12%, per the 30 July 2026 release.
• Targets sit below the price. MarketBeat lists a consensus target of $56.80 from seven analysts, with a range of $48 to $75. JPMorgan raised its target to $50 from $45 on 31 July 2026 and kept an Underweight rating. Truist rated the shares Hold with a $62 target on 22 July 2026.

Price setup

Adjusted daily closes show $71.03 on 21 October 2026, against $66.49 on 8 October 2026. The 14-day relative strength index, a momentum gauge on a 0–100 scale, rose to 67.2 from 48.4 over that span. The 52-week high is $71.34.

The $65 level is the research invalidation line, carried over from the prior note. Moving-average values, retail-attention measures and insider transactions are not available for this note. Crowding evidence is limited to the 15.6% three-month gain, the close within 0.4% of the 52-week high and an earnings date eight days away. Earnings events can move the shares by several percent in a session.

Catalysts, next 30 days

No upcoming dated catalysts on file — the dated entries below have passed.

Elapsed catalysts

• 29 October 2026 — Third-quarter 2026 results. TriNet announced on 15 October 2026 that it will report before the US market opens, with a call at 8:30 a.m. Eastern. Last year's report came on 29 October 2025. (passed 8d ago)
• 29 October 2026 — Guidance. The 2026 insurance cost ratio range of 88.5–89.5% and the revenue floor of $4.75 billion are tested for the first time without the Q2 recovery. (passed 8d ago)

What would change the view

The case breaks if the third-quarter insurance cost ratio comes in at or above 89.5%, or if TriNet cuts 2026 revenue guidance below $4.75 billion. Either would show the Q2 margin gain was the one-time recovery and not a lasting change in claims costs.

A daily close below $65 would also end the price case. That level sits below the $66.49 close of 8 October 2026 and the $71.03 close of 21 October 2026.

A ratio well below the guided range with guidance held or raised would strengthen the case. Worksite employee declines larger than the 12% seen in Q2 would weaken it regardless of the cost result.

What it trades with

TriNet is a professional employer organization (PEO), so its health-cost exposure moves with small-business claims experience rather than with insurer premiums. Insperity (NSP) runs the same model with pooled-plan cost mechanics, and its reported ratios are the closest read-through. Small-business hiring and employment levels drive TriNet's worksite employee count.